4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-25-004486
CHAIRMAN AND CEO bought 346,844 shares at $0.03 ($9,712)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Trieu Vuong CHAIRMAN AND CEO | 2025-01-29 | Purchase | +183,066 | $0.03 | $5,126 | 93,025,782 | D: show line 1 in the form |
| Trieu Vuong CHAIRMAN AND CEO | 2025-01-30 | Purchase | +100,003 | $0.03 | $2,800 | 93,125,785 | D: show line 2 in the form |
| Trieu Vuong CHAIRMAN AND CEO | 2025-01-31 | Purchase | +63,775 | $0.03 | $1,786 | 93,189,560 | D: show line 3 in the form |
| Open-market purchases · 346,844 sh · avg $0.03 · $9,712 | |||||||
Loading xslF345X05/ownership.xml…